BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31696212)

  • 1. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.
    Pasipanodya EC; Montoya JL; Campbell LM; Hussain MA; Saloner R; Paolillo EM; Jeste DV; Letendre SL; McCutchan JA; Heaton RK; Moore DJ
    Arch Clin Neuropsychol; 2021 Feb; 36(2):151-164. PubMed ID: 31696212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and neurocognitive profiles among people living with HIV and HIV-negative individuals older over 50 years: a comparison of IHDS, MMSE and MoCA.
    Chen P; Xin X; Xiao S; Liu H; Liu X; He N; Ding Y
    J Neurovirol; 2024 May; ():. PubMed ID: 38709469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.
    Saloner R; Grelotti DJ; Tyree G; Sundermann EE; Ma Q; Letendre S; Heaton RK; Cherner M
    J Acquir Immune Defic Syndr; 2019 Dec; 82(5):475-482. PubMed ID: 31714426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
    Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
    Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of Steatosis to Neurocognitive Function in People Living with HIV.
    Marić D; Brkić S; Ignjatović VB; Nikolaševic Ž; Ilić D; Vujanović M; Drvendžija Z; Galić BS
    Curr HIV Res; 2020; 18(3):172-180. PubMed ID: 32106801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.
    Saloner R; Campbell LM; Serrano V; Montoya JL; Pasipanodya E; Paolillo EW; Franklin D; Ellis RJ; Letendre SL; Collier AC; Clifford DB; Gelman BB; Marra CM; McCutchan JA; Morgello S; Sacktor N; Jeste DV; Grant I; Heaton RK; Moore DJ;
    J Int Neuropsychol Soc; 2019 May; 25(5):507-519. PubMed ID: 30890191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Evaluation of an Abbreviated Test Battery to Screen for Neurocognitive Impairment in HIV-Positive Military Members.
    Agan BK; Won SH; Ganesan A; Smith BR; Estupigan C; Maves R; Utz G; Hsieh HC; Tramont E; Nath A; Snow J
    AIDS Behav; 2021 Oct; 25(10):3347-3354. PubMed ID: 34382119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder.
    Saloner R; Morgan EE; Hussain MA; Moore DJ; Heaton RK; Cherner M; Grant I; Iudicello JE;
    J Neurovirol; 2022 Apr; 28(2):248-264. PubMed ID: 34981438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
    Métral M; Darling K; Locatelli I; Nadin I; Santos G; Brugger P; Kovari H; Cusini A; Gutbrod K; Tarr PE; Calmy A; Lecompte TD; Assal F; Monsch A; Kunze U; Stoeckle M; Schwind M; Schmid P; Pignatti R; Di Benedetto C; Du Pasquier R; Cavassini M; ;
    HIV Med; 2020 Jan; 21(1):30-42. PubMed ID: 31589807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.
    Bharti AR; McCutchan A; Deutsch R; Smith DM; Ellis RJ; Cherner M; Woods SP; Heaton RK; Grant I; Letendre SL
    Clin Infect Dis; 2016 Dec; 63(12):1655-1660. PubMed ID: 27794019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of HIV exposure and excess burden of neurocognitive impairment in people living with HIV: a protocol for systematic review and meta-analysis of controlled studies.
    Ayu AP; Rahadi A; Kristian K; Sani TP; Putra A; Halim G; Mangkuliguna G; Kusumoputri TP; Turana Y
    Syst Rev; 2023 Nov; 12(1):214. PubMed ID: 37968747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.
    McCutchan JA; Marquie-Beck JA; Fitzsimons CA; Letendre SL; Ellis RJ; Heaton RK; Wolfson T; Rosario D; Alexander TJ; Marra C; Ances BM; Grant I;
    Neurology; 2012 Feb; 78(7):485-92. PubMed ID: 22330412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent Profile Analysis of Cognitive Performance and Depressive Symptoms Among People with HIV.
    Kohli M; Ham L; Saloner R; Dung D; Iudicello J; Ellis RJ; Moore DJ
    AIDS Patient Care STDS; 2024 Feb; 38(2):93-106. PubMed ID: 38381950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive impairment in Spanish-speaking Latinos living with HIV in the US: Application of the neuropsychological norms for the US-Mexico border region in Spanish (NP-NUMBRS).
    Kamalyan L; Hussain MA; Diaz MM; Umlauf A; Franklin DR; Cherner M; Rivera Mindt M; Artiola I Fortuny L; Grant I; Heaton RK; Marquine MJ
    Clin Neuropsychol; 2021 Feb; 35(2):433-452. PubMed ID: 31847711
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurocognitive Functioning is Associated with Self-Reported and Performance-Based Treatment Management Abilities in People Living with HIV with Low Health Literacy.
    Fazeli PL; Woods SP; Lambert CC; Waldrop-Valverde D; Vance DE
    Arch Clin Neuropsychol; 2020 Jul; 35(5):517-527. PubMed ID: 32090235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Demographic Correlates, and Medical Correlates of Cognitive Impairment Among Iranian People Living With HIV: A Cross-sectional Survey Study.
    Etesami MS; Jones DL; Sadeghi-Firoozabadi V; Abbasian L; Ghayomzadeh M; Mohraz M; Vance DE; Cysique LA; Asgarabad MH
    J Assoc Nurses AIDS Care; 2022 Jul-Aug 01; 33(4):421-435. PubMed ID: 35081086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.